A case is reported of a 5-year-old boy with Lowe syndrome. The patient was unusual in that he had only mild and transient acidosis with no rickets. The corneal opacities in the parents suggest that this disease might be autosomal recessive.

Download full-text PDF

Source
http://dx.doi.org/10.1620/tjem.132.385DOI Listing

Publication Analysis

Top Keywords

variant lowe
4
lowe oculocerebrorenal
4
oculocerebrorenal syndrome
4
syndrome case
4
case reported
4
reported 5-year-old
4
5-year-old boy
4
boy lowe
4
lowe syndrome
4
syndrome patient
4

Similar Publications

Primary Progressive Aphasia Lacking Core Features of Nonfluent and Semantic Variants: Clinical, Neuroimaging, and Neuropathologic Features.

Neurology

November 2024

From the Departments of Neurology (H.W., J.R.D., H.C., J.G.-R., K.A.J.), Psychology (M.M.M.), and Radiology (N.T.T.P., V.J.L., J.L.W.), Mayo Clinic, Rochester, MN; and Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL.

Article Synopsis
  • This study investigates the limitations of the 2011 consensus criteria for primary progressive aphasia (PPA), specifically focusing on features of logopenic variant PPA and aiming to refine the classification system based on clinical and neuroimaging data.
  • A retrospective analysis of 102 PPA patients revealed a predominance of repetition-preserved variants over repetition-impaired ones, suggesting different clinical courses and potential prodromal stages among the subgroups identified (pure-LPA, Wernicke-like, anomic-like, and TCSA-like).
  • Neuroimaging showed consistent left temporoparietal atrophy across groups, with severe hypometabolism linked to repetition deficits, while pathologically, 70% of patients had Alzheimer's disease, with varying
View Article and Find Full Text PDF

The discovery of oncogene addiction in cancer has led to the development of over a dozen FDA-approved biomarker-driven therapies in lung adenocarcinoma. Somatic mutations of the "Ras-like in all tissues" (RIT1) gene are non-canonical driver events in lung cancer, occurring in ~2% of lung adenocarcinomas in a mutually exclusive fashion with and mutations. Patients with -mutant lung cancer lack targeted therapy treatment options, and a lack of pre-clinical models has hindered the development of therapeutic strategies for -mutant lung cancer.

View Article and Find Full Text PDF
Article Synopsis
  • The Notch receptor is activated by ligands from the Delta/Serrate/Lag-2 family, but the structure of its signaling complex is not fully understood.
  • This study focuses on the Notch-1 EGF 20-27 region, using advanced techniques like crystallography and NMR, revealing it has a rigid yet flexible structure influenced by calcium ions.
  • Findings indicate that variations in the Notch-1 protein affect its activation by ligands, highlighting the importance of calcium in maintaining structural integrity and the role of different interactions in Drosophila mutations.
View Article and Find Full Text PDF

Somatic mutations in the epidermal growth factor receptor (EGFR) are a major cause of non-small cell lung cancer. Among these structurally diverse alterations, exon 20 insertions represent a unique subset that rarely respond to EGFR tyrosine kinase inhibitors (TKIs). Therefore, there is a significant need to develop inhibitors that are active against this class of activating mutations.

View Article and Find Full Text PDF

Detection and Characterization of Clonal Hematopoiesis.

Methods Mol Biol

October 2024

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.

Article Synopsis
  • - Clonal hematopoiesis (CH) is the increase of specific blood stem cell clones due to genetic mutations, linked to serious health issues like cancers and cardiovascular diseases, which raise mortality risk.
  • - Lymphoid clonal hematopoiesis (L-CH) affects a wider range of genes but is less common and harder to detect compared to its myeloid counterparts.
  • - The study presents a targeted sequencing method for accurately identifying CH in bone marrow or blood samples, emphasizing DNA isolation, library preparation, and computational analysis for reliable variant detection.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!